Aims: To determine the time Colombian patients with rheumatoid arthritis (RA) are treated with non-biological disease-modifying antirheumatic drugs (DMARDs) before changing to biological therapy.
Methods: A retrospective cohort study that
Time to and factors associated with initiation of biological therapy in patients with rheumatoid arthritis in Colombia
Audifarma |
| Tiempo de lectura: Min
- Tema: Farmacoepidemiología
- Autores: Jorge E. Machado-Alba, Santiago García-Betancur, Luis F. Calvo-Torres, Diego Alejandro Medina-Morales, Alejandra M. Bañol-Giraldo
- Idiomas: Inglés
- Palabras clave: Artritis Reumatoide Análisis de Supervivencia Antirreumáticos Farmacoepidemiología ColombiaRheumatoid arthritisSurvival analysisAntirheumatic
Machado-Alba JE, García-Betancur S, Calvo-Torres L, Medina-Morales DA, Bañol-Giraldo AM. Time to and factors associated with initiation of biological therapy in patients with rheumatoid arthritis in Colombia. Revista Colombiana de Reumatología. 2018; 25(1 Enlace: https://www.sciencedirect.com/science/article/pii/S0121812317301305